AWHP expressed its support for Maryland House Bill 813, which would expand access to comprehensive obesity treatment under the Maryland Medical Assistance Program.

AWHP sent a letter to members of the New Hampshire Senate Health and Human Services Committee urging passage of SB 455.

AWHP expressed its disappointment with the recently proposed removal of MassHealth coverage for obesity management medications when prescribed solely for weight loss.

AWHP recently submitted comments to a Request for Information from the FDA asking the public to share their perspectives on how to increase access to nonprescription drugs.

AWHP urged Senate Leadership to include the Sewell Act (S.339) in the final year-end healthcare package.

AWHP urged House Leadership to include the Sewell Act (H.R.842) in the final year-end healthcare package.

AWHP provided comment ahead of a public workshop on the use of pharmacotherapy to address obesity among Nevada Medicaid beneficiaries.

AWHP urged members of the New Hampshire Senate Health and Human Services Committee to reconsider the decision to end Medicaid coverage of obesity management medications when prescribed solely for weight loss.

AWHP urged members of the New Hampshire House of Representatives Health, Human Services and Elderly Affairs Committee to reconsider the decision to end Medicaid coverage of obesity management medications when prescribed solely for weight loss.